कृपया अन्य खोज का प्रयास करें
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases. The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 1 trials in delaying the onset or progression of type 1 diabetes. Further, the company develops SAB-176, a multivalent, broadly neutralizing - human polyclonal immunoglobulin therapeutic candidate, currently in Phase 2a development for the treatment or prevention of severe influenza. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Ilan Katz | 48 | - | Director |
Jeffrey G. Spragens | 79 | 2020 | Independent Non-Executive Chairman of the Board |
Samuel J. Reich | 46 | 2020 | CEO, CFO & Director |
James J. Martin | 54 | 2020 | Independent Director |
Stephen D. Collins | 68 | 2020 | Independent Director |
William Polvino | - | 2021 | Director |
David Link | - | 2021 | Director |
Eddie Joe Sullivan | - | 2021 | Director |
Christine Hamilton | - | 2021 | Director |
Mervyn Turner | - | 2021 | Director |
Helen K. Ellias | - | 2023 | Director |
Jim Robl | - | - | Member of Scientific Advisory Board |
Scott Giberson | 54 | 2022 | Independent Director |
Stephen E. Gitelman | - | 2020 | Member of Scientific Advisory Board |
Arturo Casadevall | - | - | Member of Scientific Advisory Board |
Jeffrey G. Spragens | 82 | 2020 | Independent Director |
Mark J. Ratain | 69 | 2022 | Member of Scientific Advisory Board |
Erick J. Lucera | 56 | 2023 | Independent Director |
Juan Alvarez | - | 2022 | Member of Scientific Advisory Board |
David Charles Link | 68 | 2018 | Independent Vice Chairman |
Christine E. Hamilton | 68 | 2014 | Co-Founder & Independent Director |
Michael Haller | - | - | Member of Scientific Advisory Board |
Andrew D. Moin | 40 | 2023 | Independent Director |
William J. Polvino | 64 | 2019 | Independent Director |
Eddie Joe Sullivan | 57 | 2014 | Co-Founder, President & Director |
Helen Katherine Ellias | 45 | 2023 | Independent Director |
Jay S. Skyler | 77 | 2024 | Independent Director |
Edward D. Hamilton | - | 2021 | Co-Founder & Board Observer |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है